Rapid, 24-hour, lung function improvement with rademikibart for asthma: post hoc analyses from a phase 2b randomised trial

Michael E. Wechsler, Barry Quart, Raúl Collazo

Open source

DOI
10.1183/13993003.01278-2026
Published
2026-09-24
Container
European Respiratory Journal
Publisher
European Respiratory Society (ERS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1183/13993003.01278-2026,
  title = {Rapid, 24-hour, lung function improvement with rademikibart for asthma: post hoc analyses from a phase 2b randomised trial},
  author = {Michael E. Wechsler and Barry Quart and Raúl Collazo},
  year = {2026},
  journal = {European Respiratory Journal},
  doi = {10.1183/13993003.01278-2026},
  url = {https://doi.org/10.1183/13993003.01278-2026}
}

RIS

TY  - JOUR
TI  - Rapid, 24-hour, lung function improvement with rademikibart for asthma: post hoc analyses from a phase 2b randomised trial
AU  - Michael E. Wechsler
AU  - Barry Quart
AU  - Raúl Collazo
PY  - 2026
JO  - European Respiratory Journal
DO  - 10.1183/13993003.01278-2026
UR  - https://doi.org/10.1183/13993003.01278-2026
ER  - 

APA

Wechsler, M. E., Quart, B., & Collazo, R. (2026). Rapid, 24-hour, lung function improvement with rademikibart for asthma: post hoc analyses from a phase 2b randomised trial. European Respiratory Journal. https://doi.org/10.1183/13993003.01278-2026

Source records